STAT

Opinion: ‘Three Identical Strangers’: It’s not too late to address the ethical violations

Those harmed by an unethical 1960s study that separated twins and triplets should be helped to seek answers. This work shouldn't be left to documentary filmmakers, journalists, and the subjects…

Surprise turns to shock and then outrage. That’s the theme of “Three Identical Strangers,” a documentary film released last summer and now being screened by CNN. The film also has a less well-known precursor, “The Twinning Reaction.” Both chronicle twins and triplets born in the 1960s who were separated as infants and adopted by different families who had no idea of the other siblings’ existence.

The separation and secrecy were unethical aspects of an experiment that sought to examine the contributions of genetics and environment to child development. The children (who are now adults), their families, and the public deserve answers to many unanswered questions.

Although some aspects of the research over the ensuing decades, clear information about its aims, design, and results have never been published. The study records reside at Yale, where they were deposited by the lead researcher, Dr. Peter Neubauer, and . No one — not the subjects, reporters, filmmakers, or researchers — has been

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min readAmerican Government
STAT+: Pharmalittle: We’re Reading About FTC Reviewing Novo-Catalent Deal, Amneal Opioid Settlement, And More
The FTC wants more information on a $16.5 million deal in which Novo Nordisk's parent company would purchase Catalent, a contract drug manufacturer.
STAT2 min readChemistry
STAT+: Pharmalittle: We’re Reading About Fake Studies, AbbVie Investing In Psychedelics, And More
Fake studies have flooded publishers of top scientific journals,. leading to thousands of retractions and millions of dollars in lost revenue.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Sanofi Licensing Novavax’s Covid Shot, Moderna’s RSV Vaccine, And More
Sanofi said it has reached a licensing deal to sell Novavax’s Covid shot as well as to try to combine the vaccine with Sanofi’s own flu vaccine.

Related Books & Audiobooks